News & AnalysisEpidarex wraps up third fundEpidarex Capital, a life science venture firm, has closed its third fund at 102.1 million pounds.ByIris Dorbian22 June 2020•6 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingFundraisingHealthcareBriefs